• Corpus ID: 29042476

Prevention of perinatal group B streptococcal disease: updated CDC guideline.

@article{Cagno2012PreventionOP,
  title={Prevention of perinatal group B streptococcal disease: updated CDC guideline.},
  author={Colleen K Cagno and Jessie M Pettit and Barry D Weiss},
  journal={American family physician},
  year={2012},
  volume={86 1},
  pages={
          59-65
        }
}
Group B streptococcus is the leading cause of early-onset neonatal sepsis in the United States. Universal screening is recommended for pregnant women at 35 to 37 weeks' gestation. The Centers for Disease Control and Prevention recently updated its guideline for the prevention of early-onset neonatal group B streptococcal disease. The new guideline contains six important changes. First, there is a recommendation to consider using sensitive nucleic acid amplification tests, rather than just… 

Infeção tardia por streptococcus agalactiae – um caso de artrite séptica neonatal

This case report illustrates a late-onset GBS disease, presenting as neonatal septic arthritis on a caucasian term infant, with unknown route of transmission and highlights the morbidity associated.

Antepartum Screening for Group B Streptococcus by Three FDA-Cleared Molecular Tests and Effect of Shortened Enrichment Culture on Molecular Detection Rates

The NAATs performed comparably and were more sensitive than culture and a shortened period of broth culture enrichment resulted in 1 false-negative result in 68.

Antenatal Screening for Group B Streptococcus in the Setting of Preterm Premature Rupture of Membranes: Empiric versus Culture-based Prophylaxis

In pregnancies complicated by PPROM, babies of women who received culture-based IAP had no significant difference in EONS or GBS infection compared with infants of women with empiric IAP.

Perinatal Streptococcus agalactiae Epidemiology and Surveillance Targets

The main schemes used for GBS epidemiology are explored and the targets for epidemiological surveillance are detailed, which is vital for monitoring and therapeutics, if sufficient detail can be extracted.

High group B streptococcus carriage rates in pregnant women in a tertiary institution in Nigeria

A more expansive study in the future will be required to establish if invasive GBS neonatal disease is uncommon in Nigeria, as a significant association between frequency of intercourse of > 2 per week and GBS carriage was found.

Estimation of invasive Group B Streptococcus disease risk in young infants from case-control serological studies

Unsupervised mixture model averaging (MMA) is proposed and applied here to accurately estimate infant IGbsD risk from case-control study data in presence or absence of antibody concentration subgroups potentially associated to maternal GBS carriage or infection.

The effect of clindamycin vaginal cream on prevention of preterm labor

It seems that clindamycin in decreasing prenatal mortality is associated with preterm labor effectively, and in control group gestational age was less and mortality rate was high, although no significant difference was observed in the rate of preterm Labor between the two groups.

Aerobic bacteria on cervical cytology

Dysbacteriosis is characterized by a shift in the microbiota, with a decrease in the amount of lactobacilli accompanied by an increase of anaerobic and/or aerobic bacteria, which may serve to identify groups of patients with an increased risk for a smear with squamous abnormalities.

Antibiotics Prescriptions in the Neonatal Intensive Care Unit: How to Overcome Everyday Challenges

The current review outlines the problems faced in NICU antimicrobial prescribing and presents various solutions from the literature.

Potential Application of Bacteriophages in Enrichment Culture for Improved Prenatal Streptococcus agalactiae Screening

The feasibility of using phages to minimize the undesirable E. faecalis outgrowth and facilitate S. agalactiae detection in an experimental setting is explored.

References

SHOWING 1-10 OF 18 REFERENCES

Prevention of Perinatal Group B Streptococcal Disease

The 2002 Prevention of Perinatal Group B Streptococcal Disease guidelines from the Center for Disease Control represents a revision of a prior set of guidelines represented by the CDC in 1996, and included a recommendation for universal prenatal screening for GBS.

Update on Group B Streptococcal Infections: Perinatal and Neonatal Periods

  • R. Nandyal
  • Medicine, Biology
    The Journal of perinatal & neonatal nursing
  • 2008
Recommendations for screening, diagnosing, and treating Group B Streptococcus disease in newborns and a detailed account of recommendations is provided.

Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Although universal screening for GBS colonization is anticipated to result in further reductions in the burden of GBS disease, the need to monitor for potential adverse consequences of intrapartum antibiotic use, such as emergence of bacterial antimicrobial resistance or increased incidence or severity of non-GBS neonatal pathogens, continues.

Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.

  • J. VeraniL. McGeeS. Schrag
  • Medicine
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports
  • 2010
CDC's updated guidelines for the prevention of perinatal group B streptococcal disease have been endorsed by the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics and continue to be the cornerstones of early-onset GBS disease prevention.

Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study.

  • C. AdairL. Kowalsky H. Davies
  • Medicine
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
  • 2003
Intrauterine fetal monitoring was associated with a more than 2-fold increase in the risk of neonatal GBS disease and should be added to the list of risk factors in risk-based screening.

Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group.

Findings extend data from single hospitals and suggest prenatal screening and selective intrapartum chemoprophylaxis of high-risk mothers could potentially prevent the majority of EOD in the United States.

Risk factors for early onset neonatal group B streptococcal sepsis: case-control study

Using rupture of the membranes before the onset of labour as a risk factor might be expected to improve the success of guidelines for prophylaxis, and prevention based on risk factors might reduce the prevalence at the cost of treating many women with risk factors.

Risk Factors and Opportunities for Prevention of Early-Onset Neonatal Sepsis: A Multicenter Case-Control Study

Either prenatal GBS screening or a risk-based strategy could potentially prevent a substantial portion of GBS cases, and the severity of ampicillin-resistant E colisepsis and its occurrence after maternal antibiotics suggest caution regarding use ofAmpicillin instead of penicillin for GBS prophylaxis.

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease: A Multistate, Population-Based Analysis

The late-onset GBS disease burden remains substantial and a trivalent vaccine could be an effective prevention strategy; because many cases were born preterm, reducing the opportunity for transplacental antibody transfer, adolescent immunization should be considered.

Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement

The goal of this reaffirmation update was to find new, substantial, high-quality evidence regarding the benefits and harms of screening for asymptomatic bacteriuria in adults.